Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335 (11 August), doi:10.1136/bmj.39300.450150.BD
Rajendra Kale, senior clinical editor
rkale@bmj.com
| The first 150 words of the full text of this article appear below. |
The only thing I don't like about HINARI is its name. HINARI stands for Health InterNetwork Access to Research Initiative. I can't tell from the name that it is about meeting the information needs of researchers in developing countries. Notwithstanding its name HINARI is a success story that surprised even its organisers (doi: 10.1136/bmj.39293.711088.DE). It has inspired the world's leading publishers, the World Health Organization, Microsoft, Yale University, two individuals (Maurice Long and Barbara Aronson), and others to form a network in 113 poor countries and 2500 institutions that provides free access in these countries to 80% of Medline articles. Interestingly there are no contracts between publishers and WHO, and HINARI's diffuse network thrives on goodwill. HINARI's critics will list predictable shortcomings—access to information is not everything; information needs to be relevant to local needs; most Medline articles are not about the developing world, and so on. But health
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?